Physician profile
Amy King
NPI 1043251663
$2,768.81
in general payments reported to CMS, 2019-2025
16 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $576 · 2022: $186 · 2023: $760 · 2024: $794 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,006.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $484.15 | 2021-2025 | Lifevest |
| Medtronic, INC. | $423.98 | 2021-2024 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $375.91 | 2021-2023 | Xarelto |
| Atricure, INC. | $318.91 | 2024-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Heartflow, INC. | $243.14 | 2024 | |
| Amgen INC. | $159.43 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $151.17 | 2022-2024 | Camzyos, Eliquis |
| Abbott Laboratories | $128.56 | 2025 | Mitraclip |
| Gilead Sciences, INC. | $124.74 | 2023 | Epclusa |
| Impulse Dynamics (USA) INC. | $122.37 | 2023 | Optimizer |
| Novo Nordisk INC | $118.09 | 2024 | Wegovy |
| Pfizer INC. | $32.83 | 2021-2022 | |
| Astellas Pharma US INC | $23.26 | 2025 | Veozah |
| Astrazeneca Pharmaceuticals Lp | $22.78 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.10 | 2025 | Eohilia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $18.39 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.